‘‘(C) The Commissioner of the Food and 
Drug Administration. 
‘‘(D) The Director of the Centers for Dis-
ease Control and Prevention. 
‘‘(E) The Administrator of the National 
Oceanic and Atmospheric Administration. 
‘‘(F) The Director of the National Insti-
tute for Occupational Safety and Health. 
‘‘(G) The Administrator of the Agency for 
Toxic Substances and Disease Registry. 
‘‘(H) The Director of the Fish and Wildlife 
Service. 
‘‘(I) The Secretary of Defense. 
‘‘(J) The Administrator of the Environ-
mental Protection Agency. 
‘‘(K) The Chairman of the Consumer 
Product Safety Commission. 
‘‘(L) The Director of the National Science 
Foundation. 
‘‘(3) STAFF.—Each department or agency rep-
resented by a member on the Interagency Commis-
sion shall provide appropriate staff to carry out the 
duties of the Interagency Commission.
‘‘(4) RECOMMENDATIONS.—Not later than 12 
months after the date of enactment of the Environ-
mental Health Research Act of 2003, the Inter-
agency Commission shall recommend to the Director 
of the Institute and the Director of the USGS a re-
search program, including levels of funding for in-
tramural and extramural research. 
‘‘(5) PUBLIC COMMENT.—The Director of the 
Institute, through publication of notice in the Fed-
eral Register, shall provide the general public with 
an opportunity to comment on the recommendations 
of the Interagency Commission. 
‘‘(6) REPORT.—Not later than 4 years after the 
date of enactment of the Environmental Health Re-
search Act of 2003, the Interagency Commission 
shall conduct a review of the program established 
under subsection (a) and submit a report on the re-
sults of such review to the Director of the Institute 
and to the Hormone Disruption Research Panel es-
tablished under subsection (e). 
‘‘(7) TERMINATION.—The Interagency Commis-
sion shall terminate not later than the end of the 5-
year fiscal period described in subsection (h)(1). 
‘‘(d) FINANCIAL ASSISTANCE.—The Director of the 
Institute may provide financial assistance and enter into 
grants, contracts, and interagency memoranda of under-
standing to conduct activities under this section. Research
conducted pursuant to interagency memoranda of under-
standing may be conducted through intramural and extra-
mural agency research programs, subject to appropriate 
scientific peer review. 
‘‘(e) HORMONE DISRUPTION RESEARCH PANEL.—
‘‘(1) ESTABLISHMENT.—There is established in 
the Institute a Hormone Disruption Research Panel 
(referred to in this subsection as the ‘Panel’). 
‘‘(2) DUTIES.—The Panel shall advise the Di-
rector of the Institute concerning the scientific con-
tent of the program established under subsection 
(a), the progress of such program, and public out-
reach, and shall provide such other advice as re-
quested by the Director of the Institute. 
‘‘(3) MEMBERSHIP.—The Panel shall be com-
posed of the following: 
‘‘(A) 15 voting members to be appointed 
by the President, in consultation with the Di-
rector of the Institute. 
‘‘(B) Such nonvoting, ex officio members 
as the Director of the Institute determines to 
be appropriate. 
‘‘(4) VOTING
MEMBERS.—Of the 15 voting 
members of the Panel—
‘‘(A) at least 2 members shall be from en-
vironmental protection organizations; 
‘‘(B) at least 2 members shall be from 
public health and consumer organizations; 
‘‘(C) at least 2 members shall be from in-
dustry; 
‘‘(D) at least 1 member shall be from an 
animal welfare organization; and 
‘‘(E) a majority of the members shall be 
selected from among scientists and environ-
mental health professionals who—
‘‘(i) are not officers or employees of 
the United States; 
‘‘(ii) represent multiple disciplines, in-
cluding clinical, basic, public, and ecologi-
cal health sciences; 
‘‘(iii) represent different geographical 
regions of the United States; 
‘‘(iv) are from practice settings, aca-
demic settings, and for-profit or not-for-
profit research settings; and 
‘‘(v) have experience in review of re-
search on endocrine disruption. 
‘‘(5) TERMS.—The members of the Panel shall 
be appointed for an initial term of 3 years and shall
be eligible for reappointment for 1 additional term 
of 2 years. 
‘‘(6) CHAIRPERSON.—The members of the 
Panel appointed under paragraph (3) shall elect a 
chairperson from among such members. 
‘‘(7) MEETINGS.—The Panel shall meet at the 
call of the chairperson or upon the request of the 
Director of the Institute, but in no case less often 
than once each year. 
‘‘(8) ADMINISTRATIVE SUPPORT.—The Institute 
shall provide administrative support to the Panel. 
‘‘(9) TERMINATION.—The Panel shall terminate 
not later than the end of the 5-year fiscal period de-
scribed in subsection (h)(1). 
‘‘(f) CONFLICTS OF INTEREST.—All grants and con-
tracts entered into under this section shall include conflict-
of-interest provisions that require any person conducting 
a project under this section to disclose any other source 
of funding received by the person to conduct other related 
projects. 
‘‘(g) DEFINITIONS.—For purposes of this section: 
‘‘(1) HORMONE.—The term ‘hormone’ means a 
substance produced in a cell or tissue that triggers 
a biological response. Hormone activity may be local-
ized to the cell in which the substance is produced, 
or may be in nearby or distant tissues or organs. 
‘‘(2) HORMONE DISRUPTION.—The term ‘hor-
mone disruption’ means interference by a substance 
with the synthesis, secretion, transport, binding, ac-
tion, or elimination of natural hormones in the body 
that are responsible for the maintenance of homeo-
stasis, reproduction, development, function, or be-
havior. 
‘‘(h) AUTHORIZATION OF APPROPRIATIONS.—
‘‘(1) GENERAL
AUTHORIZATION.—There are 
authorized to be appropriated such sums as may be 
necessary for the 5-fiscal-year period beginning with 
fiscal year 2004 to carry out this section. Amounts 
appropriated pursuant to this paragraph shall re-
main available until expended. 
‘‘(2) RESTRICTIONS ON USE OF FUNDS.— 
‘‘(A) CONSTRUCTION
AND
REHABILITA-
TION
OF
FACILITIES
AND
EQUIPMENT.—Not 
more than 0.5 percent of the funds made avail-
able under this section may be used for the con-
struction or rehabilitation of facilities or fixed 
equipment. 
‘‘(B) ADMINISTRATIVE EXPENSES OF THE 
DIRECTOR.—Of the total amount of funds made